ClinicalTrials.Veeva

Menu

Diagnostic Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples

H

Heidelberg University

Status

Unknown

Conditions

Focus: Immunocompromised Individuals at High Risk of Aqcuiring Invasive Aspergillosis

Study type

Observational

Funder types

Other

Identifiers

NCT01614145
CSF Aspergillus PCR

Details and patient eligibility

About

Multicentre, diagnostic study evaluating the performance of an aspergillus-specific PCR in cerebrospinal fluid samples of immunocompromised patients for identification of central nervous system aspergillosis.

Enrollment

200 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Host factors
  • Informed consent

Exclusion criteria

  • none

Trial design

200 participants in 2 patient groups

Proven/probable CNS IA
Description:
Immunocompromised patients with proven/probable invasive CNS Aspergillosis based on modified criteria by the EORTC/MSG
Possible/No CNS IA
Description:
Immunocompromised patients with possible/NoIA invasive CNS Aspergillosis based on modified criteria by the EORTC/MSG

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems